Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Behavioural Brain Research

• Publication date

  2006-09-25

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.BBR.2006.05.011PMID 16806519
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects.

  2013cited by this paper
• Substance P Neurokinin 1 Receptor Activation within the Dorsal Raphe Nucleus Controls Serotonin Release in the Mouse Frontal Cortex

  2007cited by this paper
• Microdialysis approach to study serotonin outflow in mice following selective serotonin reuptake inhibitors and substance P (neurokinin 1) receptor antagonist administration: a review.

  2006cited by this paper
• Potentiation of antidepressant-like activity with lithium: mechanism involved.

  2006cited by this paper
• Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder.

  2006cited by this paper
• Innovative approaches for the development of antidepressant drugs: Current and future strategies

  2005cited by this paper
• Do substance P and the NK1 receptor have a role in depression and anxiety?

  2005cited by this paper
• Strategies for producing faster acting antidepressants.

  2005cited by this paper
• Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat.

  2005cited by this paper
• Cerebral blood flow changes after treatment of social phobia with the neurokinin-1 antagonist GR205171, citalopram, or placebo.

  2005cited by this paper
• A comparison of neurokinin 1 receptor knock-out (NK1-/-) and wildtype mice: exploratory behaviour and extracellular noradrenaline concentration in the cerebral cortex of anaesthetised subjects.

  2005cited by this paper
• No modulatory effect of neurokinin-1 receptor antagonists on serotonin uptake in human and rat brain synaptosomes.

  2005cited by this paper
• Sustained pharmacological blockade of NK1 substance P receptors causes functional desensitization of dorsal raphe 5‐HT1A autoreceptors in mice

  2005cited by this paper
• A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests.

  2005cited by this paper
• Issues in treatment-resistant depression.

  2005cited by this paper
• Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: comparison with antidepressant drugs.

  2005cited by this paper
• Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response.

  2004cited by this paper
• Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice

  2004influential reference
• du CRSN : le point sur la dépression , première partie Impact of substance P receptor antagonism on the serotonin and norepinephrine systems : relevance to the antidepressant / anxiolytic response

  2004cited by this paper
• Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms?

  2004cited by this paper
• Substance P in the medial amygdala: Emotional stress-sensitive release and modulation of anxiety-related behavior in rats

  2004cited by this paper
• Is the forced swimming test a suitable model for revealing antidepressant activity?

  2004cited by this paper
• The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review.

  2004cited by this paper
• Demonstration of the Efficacy and Safety of a Novel Substance P (NK1) Receptor Antagonist in Major Depression

  2004cited by this paper
• S.13.05 Peptide approaches in the treatment of major depression — lack of efficacy of the substance P (neurokinin1 receptor) antagonist aprepitant

  2004cited by this paper
• Forced swimming test in mice: a review of antidepressant activity

  2004cited by this paper
• Comparison of the functional blockade of rat substance P (NK1) receptors by GR205171, RP67580, SR140333 and NKP-608.

  2003cited by this paper
• The antidepressant-like effects of neurokinin NK1 receptor antagonists in a gerbil tail suspension test

  2003cited by this paper
• Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse.

  2003cited by this paper
• Antidepressant-like effects in various mice strains in the tail suspension test.

  2003cited by this paper
• The pharmacology of putative early-onset antidepressant strategies.

  2003cited by this paper
• Antidepressant-like effects in various mice strains in the forced swimming test

  2003cited by this paper
• First dual NK(1) antagonists-serotonin reuptake inhibitors: synthesis and SAR of a new class of potential antidepressants.

  2002cited by this paper
• [Mechanism of action of antidepressants and therapeutic perspectives].

  2002cited by this paper
• Clinical experience with substance P receptor (NK1) antagonists in depression.

  2002cited by this paper
• Dual NK(1) antagonists--serotonin reuptake inhibitors as potential antidepressants. Part 2: SAR and activity of benzyloxyphenethyl piperazine derivatives.

  2002cited by this paper
• Substance P (Neurokinin 1) Receptor Antagonists Enhance Dorsal Raphe Neuronal Activity

  2002cited by this paper
• The selective neurokinin (NK)(1) antagonist, GR205,171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological study.

  2002cited by this paper
• Pharmacology of antidepressants.

  2001cited by this paper
• Comparison of the phenotype of NK1R−/− mice with pharmacological blockade of the substance P (NK 1 ) receptor in assays for antidepressant and anxiolytic drugs

  2001cited by this paper
• Comparison of the phenotype of NK1R / mice with ( ) pharmacological blockade of the substance P NK1 receptor in assays for antidepressant and anxiolytic drugs

  2001cited by this paper
• Research and treatment approaches to depression

  2001cited by this paper
• Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function.

  2001cited by this paper
• Selective blockade of neurokinin (NK)1 receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats

  2001cited by this paper
• 5-Hydroxytryptamine (5-HT)1A Autoreceptor Adaptive Changes in Substance P (Neurokinin 1) Receptor Knock-Out Mice Mimic Antidepressant-Induced Desensitization

  2001cited by this paper
• Effect of neurokinin‐1 receptor antagonists on the function of 5‐HT and noradrenaline neurons

  2000cited by this paper
• The tachykinin NK1 receptor in the brain: pharmacology and putative functions.

  1999cited by this paper
• Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions.

  1999cited by this paper
• Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems.

  1998influential reference
• Distinct mechanism for antidepressant activity by blockade of central substance P receptors.

  1998influential reference
• Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test

  1998cited by this paper
• Pharmacology of antidepressants.

  1997cited by this paper
• Buspirone Enhances Duloxetine‐ and Fluoxetine‐Induced Increases in Dialysate Levels of Dopamine and Noradrenaline, but Not Serotonin, in the Frontal Cortex of Freely Moving Rats

  1997cited by this paper
• Differential effects of clonidine, lithium and quinine in the forced swimming test in mice for antidepressants: possible roles of serotoninergic systems.

  1996cited by this paper
• [Central serotonin receptors and chronic treatment with selective serotonin reuptake inhibitors in the rat: comparative effects of fluoxetine and paroxetine].

  1995influential reference
• Behavioral models in mice. Implication of the alpha noradrenergic system.

  1991cited by this paper
• Effect of immobilization stress on neuropeptides and their receptors in rat central nervous system.

  1986cited by this paper
• Depression: a new animal model sensitive to antidepressant treatments

  1977cited by this paper
• [Action of caffeine on the spontaneous motility of the mouse].

  1965cited by this paper

• Nose-to-Brain Delivery of Chitosan-Grafted Leciplexes for Promoting the Bioavailability and Antidepressant Efficacy of Mirtazapine: In Vitro Assessment and Animal Studies

  2025cites this paper
• Synthesis of anti-depressant molecules via metal-catalyzed reactions: a review

  2024cites this paper
• Dual 5-HT6/SERT ligands for mitigating neuropsychiatric symptoms of dementia exerting neuroprotection against amyloid-β toxicity, memory preservation, and antidepressant-like properties.

  2024cites this paper
• Sargassum pallidum reduces inflammation to exert antidepressant effect by regulating intestinal microbiome and ERK1/2/P38 signaling pathway

  2024cites this paper
• Increased BDNF and hippocampal dendritic spine density are associated with the rapid antidepressant-like effect of iron-citalopram and iron-imipramine combinations in mice.

  2023cites this paper
• Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: II. Antidepressant Effect in an Experimental Animal Model

  2023cites this paper
• Chimeric Structures in Mental Illnesses—“Magic” Molecules Specified for Complex Disorders

  2022cites this paper
• UPLC-MS/MS-based profiling of 31 neurochemicals in the mouse brain after treatment with the antidepressant nefazodone

  2021cites this paper
• Visualization and Quantification of Neurokinin-1 receptors in Human Brain With Positron Emission Tomography

  2019cites this paper
• Brain neurokinin-1 receptor availability in never-medicated patients with major depression - A pilot study.

  2019cites this paper
• The Hypothalamic–Pituitary–Adrenal Axis and Serotonin Metabolism in Individual Brain Nuclei of Mice with Genetic Disruption of the NK1 Receptor Exposed to Acute Stress

  2018cites this paper
• The Antidepressant Activity of Matricaria chamomilla and Melissa officinalis Ethanolic Extracts in Non-Reserpinized and Reserpinized Balb/C Mice

  2018cites this paper
• اثرات ضد افسردگی اسانس اسطوخودوسLavandula angustifolia Mill و بهار نارنجCitrus bigardia Duh. بر موش های Balbc رزرپینه شده

  2017cites this paper
• Therapeutic Strategies for Treatment of Inflammation-related Depression

  2017cites this paper
• Protective role of b escitalopram antidepressant drug induced hepatotoxicity in Swiss albino

  2017influential citation
• Antidepressant- like effect of essential oil of Lavandula angustifolia Mill and Citrus bigaradia Duh in mice.

  2016cites this paper
• Discovery of Indazoles as Potent, Orally Active Dual Neurokinin 1 Receptor Antagonists and Serotonin Transporter Inhibitors for the Treatment of Depression.

  2016cites this paper
• Endogenous vasoactive mediators in defense of portal hypertensive gastric mucosa

  2015cites this paper
• Biaryls as potent, tunable dual neurokinin 1 receptor antagonists and serotonin transporter inhibitors.

  2015cites this paper
• Brain delivery of intranasal in situ gel of nanoparticulated polymeric carriers containing antidepressant drug: behavioral and biochemical assessment

  2015cites this paper
• Enhanced Responsiveness to Selective Serotonin Reuptake Inhibitors during Lactation

  2015cites this paper
• Antidepressant effect of ketamine in sub anaesthetic doses in male albino mice.

  2014cites this paper
• Discovery of a cyclopentylamine as an orally active dual NK1 receptor antagonist-serotonin reuptake transporter inhibitor.

  2014cites this paper
• The antidepressant-like effects of topiramate alone or combined with 17β-estradiol in ovariectomized Wistar rats submitted to the forced swimming test

  2014cites this paper
• Discovery of disubstituted piperidines and homopiperidines as potent dual NK1 receptor antagonists-serotonin reuptake transporter inhibitors for the treatment of depression.

  2013cites this paper
• NK1 receptor antagonism lowers occupancy requirement for antidepressant-like effects of SSRIs in the gerbil forced swim test.

  2013cites this paper
• Development of a Scalable Route to a Dual NK-1/Serotonin Receptor Antagonist

  2013cites this paper
• Design, optimization, and in vivo evaluation of a series of pyridine derivatives with dual NK1 antagonism and SERT inhibition for the treatment of depression.

  2013cites this paper
• Combined NK1 antagonism and serotonin reuptake inhibition: effects on emotional processing in humans

  2013cites this paper
• A physico-chemical approach

  2012cites this paper
• Compatibility of paroxetine hydrochloride and GW597599B

  2012cites this paper
• Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs

  2011cites this paper
• Modulating amygdala responses to emotion: evidence from pharmacological fMRI.

  2011cites this paper
• Re view Article NEW INSIGHTS INTO MOLECULAR TARGETS FOR DEPRESSION

  2011cites this paper
• S41744, a dual neurokinin (NK)1 receptor antagonist and serotonin (5-HT) reuptake inhibitor with potential antidepressant properties: a comparison to aprepitant (MK869) and paroxetine.

  2010cites this paper
• Pathogenic involvement of neuropeptides in anxiety and depression.

  2010cites this paper
• Behavioral effects of neuropeptides in rodent models of depression and anxiety.

  2010cites this paper
• Use of latency to immobility improves detection of antidepressant-like activity in the behavioral despair test in the mouse.

  2009cites this paper
• Neurokinin1 Antagonists Potentiate Antidepressant Properties of Serotonin Reuptake Inhibitors, Yet Blunt Their Anxiogenic Actions: A Neurochemical, Electrophysiological, and Behavioral Characterization

  2009cites this paper
• Influence of Sex and CRF Pathways as Determinants in 5-HT Sensitivity Abbreviated title: Sex and Stress in 5-HT Sensitivity

  2009cites this paper
• Emerging targets for antidepressant therapies.

  2009cites this paper
• NMDA receptor/nitrergic system blockage augments antidepressant-like effects of paroxetine in the mouse forced swimming test

  2009cites this paper
• Influence of sex and corticotropin-releasing factor pathways as determinants in serotonin sensitivity.

  2009cites this paper
• Tachykinin receptors as therapeutic targets in stress-related disorders.

  2009cites this paper
• The Discovery and Development of Pharmacotherapy for Psychiatric Disorders: A Critical Survey of Animal and Translational Models and Perspectives for Their Improvement

  2008cites this paper
• Antidepressant-like actions of minocycline combined with several glutamate antagonists.

  2008cites this paper
• Novel targets for antidepressant therapies

  2008cites this paper
• Depression: Chemical Mechanisms

  2008cites this paper
• Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders.

  2008cites this paper
• Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agents.

  2008cites this paper
• Assessing the Neuronal Serotonergic Target-based Antidepressant Stratagem: Impact of In Vivo Interaction Studies and Knockout Models

  2008cites this paper
• Neurokinin 1 receptor antagonism promotes active stress coping via enhanced septal 5-HT transmission

  2007cites this paper
• Enhanced selective serotonin re-uptake inhibitors as antidepressants: 2004 – 2006

  2007cites this paper
• Neurokinin 1 receptor antagonism promotes active stress coping via enhanced septal 5-HT transmission

  2007cites this paper
• Molecular alterations of AMPA receptors and their effects on hippocampus dependent tasks

  2007cites this paper
• Innovations in CNS drug discovery: differentiating strategies to treat depression

  2007cites this paper
• Older versus newer antidepressants: substance P or calcium antagonism?

  2007cites this paper
• Acta Universitatis Upsaliensis Uppsala 2015

  year unknowncites this paper